Prevention of Opioid Misuse and Overdose Deaths Among Hispanic/Latinx Adolescents: A Family-based Perspective

April 2, 2026 updated by: Alejandra Fernandez, The University of Texas Health Science Center, Houston
The purpose of this study is to develop culturally-competent family-focused educational modules targeting opioid knowledge and attitudes (including targeting safe storage and prevention of accidental opioid overdose in adolescent populations) and examine changes acceptability, knowledge, and attitudes scores

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • The University of Texas Health Science Center at Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Must identify as Hispanic/Latino/a descent
  • Have an adolescent between the ages of 15 and 17 years old living in their home a majority of the time
  • Have English or Spanish proficiency

Exclusion Criteria:

  • Adolescent or parent currently in opioid treatment
  • Parent self-reports a substance use (including opioid use) disorder for themselves or adolescent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Educational videos arm
Behavioral: Educational videos
Participants will be delivered a link to complete demographic information and the initial assessment. Upon completing the (initial) pre-test knowledge assessment, participants will be sent links to the three educational videos staggered across 7 days. Educational videos will determine gaps in knowledge related to opioid use and overdose based on questionnaire responses. Upon the completion of the 7 days, participants will be sent a link to the (final) post-test knowledge assessment to complete.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of the educational materials presented via the educational videos, including cultural congruence as assessed by a questionnaire
Time Frame: end of study (Day 7)
This questionnaire has 10 questions that is measured on a Likert scale from 1-4, higher number indicating more acceptability.
end of study (Day 7)
Changes in opioid related knowledge as assessed by a questionnaire
Time Frame: Baseline, end of study (Day 7)

This has 3 subscales

  1. Brief Opioid Overdose Knowledge (BOOK)

    This has 12 questions and each is scored from 0(true), 1(false) for a maximum score of 12, higher score indicating more knowledge

  2. Opioid Overdose Knowledge Scale (OOKS)

    This has 9 questions, and participants have to identify all correct answers. Score ranges from 0(no correct answers) -33 (identified all correct answers) higher score indicates more knowledge

  3. Opioid Overdose Attitude Scale (OOAS)

This has 28 questions scored on a Likert scale from 1(completely disagree)-5(completely agree), higher number indicating more positive attitude
Baseline, end of study (Day 7)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The University of Texas Health Science Center, Houston

Investigators

  • Principal Investigator: Alejandra Fernandez, PhD, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2024

Primary Completion (Actual)

April 21, 2024

Study Completion (Actual)

April 21, 2024

Study Registration Dates

First Submitted

March 4, 2024

First Submitted That Met QC Criteria

March 4, 2024

First Posted (Actual)

March 12, 2024

Study Record Updates

Last Update Posted (Actual)

April 7, 2026

Last Update Submitted That Met QC Criteria

April 2, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HSC-SPH-23-0837

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe